Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis for Neuropathic Pain and Spasticity in SCI
NCT06190470Phase 1Enrolling by invitation
- Sponsor
- Khon Kaen University
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in neuropathic pain and spasticity comparing Sequence A (Cannabis first) with Sequence B (Placebo first) (2 arms). Primary endpoint: Pain score at 2 weeks. Started Jan 2024; status: enrolling by invitation.
02
Drugs
cannabis
03
Conditions
neuropathic painspasticity
Beyond the preview
Go deeper on NCT06190470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06190470.